Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Authors:
- 1 November 2018
- Vol. 72 (21) , 2551-2562
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysisEuropean Heart Journal, 2014
- Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure PatientsJACC: Heart Failure, 2013
- Use of Amino-Terminal Pro–B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic DysfunctionJACC, 2011
- Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse careEuropean Journal of Clinical Investigation, 2010
- Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trialAmerican Heart Journal, 2009
- Monitoring clinical changes in patients with heart failure: A comparison of methodsAmerican Heart Journal, 2005
- Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass SurgeryNew England Journal of Medicine, 1997
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)The American Journal of Cardiology, 1989
- The CES-D ScaleApplied Psychological Measurement, 1977